Phase I study of [68Ga]Ga-HX01 for targeting integrin αvβ3 and CD13 in healthy and malignancy subjects
European Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.1007/s00259-024-07002-3 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Xiao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, 4…. Hauptthemen laut MEDLINE: Integrin alphaVbeta3, Neoplasms, Gallium Radioisotopes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Provincial Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, 430022, Hubei, China.
- Hubei Key Laboratory of Molecular Imaging, Wuhan, 430022, Hubei, China.
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, 430022, Wuhan, Hubei, China.
- Hexin (Suzhou) Pharmaceutical Technology Co., Ltd, Taicang, 215421, Jiangsu, China.
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Ave, Wuhan, 430022, Hubei, China. gykmail@hust.edu.cn.
- Hubei Key Laboratory of Molecular Imaging, Wuhan, 430022, Hubei, China. gykmail@hust.edu.cn.
ORCID-Profile: Xiaoli Lan
Förderung
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation
Zitieren
APA
Zhang, X., Fang, H., Yang, B., Qin, C., Hu, F., Ruan, W., Chen, J., Zeng, D., Gai, Y., & Lan, X. (2025). Phase I study of [68Ga]Ga-HX01 for targeting integrin αvβ3 and CD13 in healthy and malignancy subjects. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-07002-3
Vancouver
Zhang X, Fang H, Yang B, Qin C, Hu F, Ruan W, et al. Phase I study of [68Ga]Ga-HX01 for targeting integrin αvβ3 and CD13 in healthy and malignancy subjects. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-024-07002-3
BibTeX
@article{Zhang2025,
author = {Zhang, Xiao and Fang, Hanyi and Yang, Biao and Qin, Chunxia and Hu, Fan and Ruan, Weiwei and Chen, Jing and Zeng, Dexing and Gai, Yongkang and Lan, Xiaoli},
title = {Phase I study of [68Ga]Ga-HX01 for targeting integrin αvβ3 and CD13 in healthy and malignancy subjects},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.1007/s00259-024-07002-3}
}
EUVIMED